ONCORUS
Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.
ONCORUS
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-04-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.oncorus.com
Total Employee:
11+
Status:
Active
Contact:
(857)320-6402
Email Addresses:
[email protected]
Total Funding:
218.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Oncorus
Arkin Bio Ventures
Arkin Bio Ventures investment in Series B - Oncorus
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Oncorus
Perceptive Advisors
Perceptive Advisors investment in Series B - Oncorus
Celgene
Celgene investment in Series B - Oncorus
Deerfield
Deerfield investment in Series B - Oncorus
Sphera Funds Management
Sphera Funds Management investment in Series B - Oncorus
Shinhan Private Equity
Shinhan Private Equity investment in Series B - Oncorus
SV Investment Partners
SV Investment Partners investment in Series B - Oncorus
UTC Investment Co.
UTC Investment Co. investment in Series B - Oncorus
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-10 | Oncorus Announces Appointment of Richard Wanstall as Chief Financial Officer |
| 2022-02-22 | Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical Officer |
